glp-1 agonists cancer risk Could medications help slow progression? A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to Forest plot of GLP-1 receptor
Description
Survodutide is also being studied in Phase 3 trials for the treatment of MASH
Given the proportions of missing data for eGFR, BMI and other variables (ESM Table 2), we used multiple imputations (Markov chain Monte Carlo method) to handle missing data
Devices sold under the brand names Precision and NovaMax combine both blood glucose meters and ketone tests in one small unit for around $30
10.1126/science.aau6499 13 ElsiadE
All data from the report will also be delivered in an excel dashboard format
Bottom line: MeAgain treats shot day as the start of daily follow-through, not the whole job
